GHCM
TWST icon

Glen Harbor Capital Management’s Twist Bioscience TWST Stock Holding History

Glen Harbor Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$749K Buy
31,348
+29,920
+2,095% +$870K 0.02% 555
2019
Q2 		$41K Buy
1,428
+714
+100% +$18.9K ﹤0.01% 1262
2019
Q1 		$17K Sell
714
-544
-43% -$12.3K ﹤0.01% 1283
2018
Q4 		$29K Buy
+1,258
New +$27.9K ﹤0.01% 1210

Other funds holding TWST

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return

Glen Harbor Capital Management's TWST Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Twist Bioscience (TWST) stake by 2,095% in Q3 2019, buying an estimated $870K and bringing the position to 31,348 shares worth $749K. The position accounts for 0.02% of the portfolio, ranked #555.

Glen Harbor Capital Management first reported a position in TWST in Q4 2018 and has held it in 4 quarters since. 84 funds tracked by Wall St. Rank hold TWST as of Q3 2019.

  • Glen Harbor Capital Management held 31,348 shares of Twist Bioscience worth $749K as of Q3 2019.
  • Glen Harbor Capital Management bought 29,920 Twist Bioscience shares in Q3 2019, an estimated $870K.
  • Twist Bioscience made up 0.02% of Glen Harbor Capital Management's portfolio in Q3 2019, its #555 holding.
  • Glen Harbor Capital Management first reported a position in Twist Bioscience in Q4 2018 and has held it in 4 quarters since.
  • 84 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.